Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft Versus Host Disease in Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00001966
What this trial is testing

Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome

Who this might be right for
Ehlers-Danlos SyndromePain
National Human Genome Research Institute (NHGRI) 40
Large-scale testing (Phase 3)Study completedNCT05774639
What this trial is testing

Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Kashiv BioSciences, LLC 600
Large-scale testing (Phase 3)UnknownNCT04944602
What this trial is testing

Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 340
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07783412
What this trial is testing

Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum

Who this might be right for
Pyoderma Gangrenosum
Oregon Health and Science University 12
Not applicableStudy completedNCT04472546
What this trial is testing

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

Who this might be right for
AcneAtopic DermatitisPsoriasis Vulgaris+3 more
Pierre Fabre Dermo Cosmetique 210
Early research (Phase 1)Study completedNCT01828086
What this trial is testing

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 95
Post-approval studies (Phase 4)Study completedNCT00336973
What this trial is testing

Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent

Who this might be right for
Psoriasis
Genentech, Inc. 73
Testing effectiveness (Phase 2)Ended earlyNCT00188669
What this trial is testing

The Use of Pentoxifylline and Vitamin E in the Treatment of Chronic Breast Pain

Who this might be right for
Breast Neoplasms
University Health Network, Toronto 48
Not applicableEnded earlyNCT04577183
What this trial is testing

A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1

Who this might be right for
Diabetic Foot UlcerPressure UlcerVenous Leg Ulcer+3 more
RedDress Ltd. 13
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Not applicableStudy completedNCT04185558
What this trial is testing

Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs

Who this might be right for
Diabetic FootChronic Ulcer
RedDress Ltd. 119
Large-scale testing (Phase 3)Not Yet RecruitingNCT06232421
What this trial is testing

Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process

Who this might be right for
Diabetic Foot InfectionsChronic Venous Insufficiency
Research Institute for Physical Chemical Problems of the Belarusian State University 224
Post-approval studies (Phase 4)Study completedNCT01390649
What this trial is testing

A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenic Purpura
CSL Behring 57
Not applicableUnknownNCT06544343
What this trial is testing

Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSystemic Lupus Erythematosus+3 more
University Of Perugia 190
Large-scale testing (Phase 3)Study completedNCT00450658
What this trial is testing

Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers

Who this might be right for
Peptic Ulcer
Amgen 627
Post-approval studies (Phase 4)Study completedNCT00832585
What this trial is testing

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Rush University Medical Center 5
Large-scale testing (Phase 3)Ended earlyNCT04210843
What this trial is testing

Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 1,033
Not applicableUnknownNCT05146843
What this trial is testing

The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients

Who this might be right for
Breast Neoplasms
D'Or Institute for Research and Education 44
Not applicableActive Not RecruitingNCT02194387
What this trial is testing

Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members

Who this might be right for
Body Mass Index 25 or GreaterBRCA1 Gene MutationBRCA2 Gene Mutation+8 more
M.D. Anderson Cancer Center 337
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07221565
What this trial is testing

Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisMultiple Sclerosis+3 more
Truway Health, Inc. 120
Next Page